Immunocore Holdings Q4 Earnings Report: What Investors Need to Know
Benzinga Insights 8 months ago
Earnings
Immunocore Holdings (NASDAQ:IMCR) announced its Q4 earnings on Wednesday, February 25, 2026 at 07:00 AM.
Here's a breakdown of the earnings report.
Earnings
Immunocore Holdings missed estimated earnings by -160.87%, reporting an EPS of $-0.6 versus an estimate of $-0.23.
Revenue was up $20.43 million from the same period last year.
Overview of Past Earnings
During the previous quarter, the company beat on EPS by $0.26, leading to a 6.03% increase share price change the next day.
Here's a look at Immunocore Holdings's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.26 | -0.21 | -0.41 | -0.24 |
| EPS Actual | 0 | -0.20 | 0.10 | -0.47 |
| Revenue Estimate | 101.06M | 92.59M | 86.45M | 83.55M |
| Revenue Actual | 103.69M | 97.96M | 93.88M | 84.05M |
To track all earnings releases for Immunocore Holdings visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.